Department of Medical Genetics, Zhongshan School of Medicine, Sun Yat-sen University, China.
Department of Medical Genetics, Zhongshan School of Medicine, Sun Yat-sen University, China.
Gene. 2019 Aug 15;709:65-74. doi: 10.1016/j.gene.2019.05.045. Epub 2019 May 23.
Autosomal recessive non-syndromic hearing loss (ARNSHL) is a highly heterogeneous genetic disease. PDZD7 is a new ARNSHL associated gene. Until now, nine PDZD7 biallelic mutation families with ARNSHL have been reported. Here we report a case of Chinese patient with ARNSHL linked to novel mutations in PDZD7 genes.
The pathogenic mutations were detected by whole exome sequencing for hereditary deafness-related genes of both the proband and his parents. We used kinship detection, mutational hazard prediction, genotype-phenotype correlation analysis and variation screening for potential pathogenic mutations. Re-sequencing was used to confirm the mutations by Sanger sequence. Real time quantitative PCR (RT-qPCR) was used to analyze the PDZD7 gene expression. Population-based screening for variation frequency, evolutionary conservation comparisons, pathogenicity evaluation, and protein structure prediction were conducted to assess the pathogenicity of the novel mutations of PDZD7 gene.
We determined three variants of the PDZD7 gene that contributed to the deafness of the patient (PDZD7 c.192G > A, p. Met64Ile; c.1648C > T p. Gln550* and c.2341_2352delCGCAGCCGCAGCp. Arg781_Ser 784del). Pathogenic analysis in accordance with the ACMG/AMP Standards and Guidelines identified two novel mutations as Likely Pathogenic. The expression level of PDZD7 gene in the patient was decreased compared to the normal control (P < 0.001).
Three mutations in PDZD7 gene linked to ARNSHL were identified in a Chinese pedigree. The findings expand not only our knowledge of genetic causes of ARNSHL, but also PDZD7 genes mutation spectrum of the disease. They will aid personalized genetic counseling, molecular diagnostics and clinical management of this condition.
常染色体隐性非综合征型耳聋(ARNSHL)是一种高度异质性的遗传疾病。PDZD7 是一种新的与 ARNSHL 相关的基因。迄今为止,已经报道了 9 个 PDZD7 双等位基因突变的 ARNSHL 家系。在这里,我们报告了一个中国 ARNSHL 患者与 PDZD7 基因的新突变相关的病例。
通过对先证者及其父母的遗传性耳聋相关基因进行全外显子组测序,检测致病突变。我们使用亲缘关系检测、突变危险预测、基因型-表型相关性分析和潜在致病突变的变异筛选。通过 Sanger 测序对重新测序进行突变确认。实时定量 PCR(RT-qPCR)用于分析 PDZD7 基因的表达。进行人群变异频率筛查、进化保守性比较、致病性评估和蛋白质结构预测,以评估 PDZD7 基因突变的致病性。
我们确定了 PDZD7 基因的三个变体导致了患者的耳聋(PDZD7 c.192G>A,p.Met64Ile;c.1648C>T p.Gln550*和 c.2341_2352delCGCAGCCGCAGCp.Arg781_Ser784del)。根据 ACMG/AMP 标准和指南进行的致病性分析确定了两个新的突变为可能致病性。与正常对照组相比,PDZD7 基因在患者中的表达水平降低(P<0.001)。
在中国一个家系中发现了三个与 ARNSHL 相关的 PDZD7 基因突变。这些发现不仅扩展了我们对 ARNSHL 遗传病因的认识,而且扩展了 PDZD7 基因疾病突变谱。它们将有助于对此病进行个性化的遗传咨询、分子诊断和临床管理。